Bispecifics and Multivalent Antibodies
13th June 2012 — 14th June 2012
PART OF OUR EMPOWERED ANTIBODIES CONGRESS 2012
Bispecifics and Multivalent Antibodies 2012: Europe's leading conference in showcasing cutting-edge multivalent platforms and providing pre-clinical and clinical data from the leading biopharmaceutical companies. Discover the latest approaches for multivalent formats and their therapeutic applications.
With over 20 industry case studies from leading companies in the field such as Micromet, Merrimack, F-Star, Abbott, Genentech, Pfizer and many more, this is THE conference for those looking to future their antibody development, and discover how to optimise targeting and ensure efficient drug potency.
Key sessions to be discussed include antibody discovery, target selection, bispecific engineering, ehanced tumour targeting, CMC and regulatory development considerations, preclinical and clinical strategies and multivalency
Expected Number of Attendees
View Conference Website: Bispecifics and Multivalent Antibodies
Price of Attendance
Hotel Palace Berlin
Budapester Straße 45